NCT07262372 Supervision in Substance Use Disorder Treatment Programs
| NCT ID | NCT07262372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arkansas |
| Condition | Self Efficacy |
| Study Type | INTERVENTIONAL |
| Enrollment | 43 participants |
| Start Date | 2025-07-21 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 43 participants in total. It began in 2025-07-21 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Substance use disorders such as opioid addiction affect millions of adults in the United States each year, but the delivery of high-quality, effective addiction services is disrupted by organizational issues such as counselor burnout and turnover. Clinical supervisors are essential for supporting counselors in specialty addiction treatment programs, but few supervisors receive supervision-focused training. This project seeks to develop and pilot an evidence-based supervision strategy that has a high potential to enhance supervision and result in improved counselors' well-being and performance and, in turn, to improve client outcomes.
Eligibility Criteria
Inclusion Criteria: * Serves as a supervisor (i.e., oversee work of counselors) or counselor (i.e., directly work with clients) at a substance use treatment facility/program * Program/facility provides residential services Exclusion Criteria: * Supervisors contracted (not employed) by the facility
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07262372 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Self Efficacy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07262372 currently recruiting?
Yes, NCT07262372 is actively recruiting participants. Contact the research team at jbaloh@uams.edu for enrollment information.
Where is the NCT07262372 trial being conducted?
This trial is being conducted at Little Rock, United States.
Who is sponsoring the NCT07262372 clinical trial?
NCT07262372 is sponsored by University of Arkansas. The trial plans to enroll 43 participants.